Phreesia, Inc. (NYSE: PHR) Investor Alert: Deadline in Lawsuit on July 13, 2026

A deadline is coming up on July 13, 2026 in the lawsuit filed for certain investors of Phreesia, Inc. (NYSE: PHR) over alleged securities laws violations by Phreesia, Inc.

Investors who purchased shares of Phreesia, Inc. (NYSE: PHR) have certain options and there are strict and short deadlines running. Deadline: July 13, 2026. Phreesia, Inc. (NYSE: PHR) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Wilmington, DE Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Phreesia, Inc. (NYSE: PHR) reported that its Total Revenue rose from $419.81 million for 12 months period that ended on January 31, 2025, to $480.59 million for 12 months period that ended on January 31, 2026, and that its Net Loss of $58.52 million for the 12 months period that ended on January 31, 2025, turned to a Net Income of 2.3 million for 12 months period that ended on January 31, 2026.

On March 30, 2026, Phreesia, Inc. announced significantly reduced revenue growth projections for fiscal year 2027 guidance. The Company attributed the shortfall relative to its prior guidance to a combination of macroeconomic factors including "worsening visibility" and weaker pharmaceutical marketing commitments within its Network Solutions segment.

Shares of Phreesia, Inc. (NYSE: PHR) declined from $32.76 per share on August 28, 2025, to as low as $7.77 per share on March 31, 2026

According to the complaint filed in the U.S. District Court for the District of Delaware the plaintiff alleges on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) common shares between May 8, 2025, to March 30, 2026, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 8, 2025, to March 30, 2026, the defendants made false and/or misleading statements and/or failed to disclose that the defendants created the false impression that they possessed reliable information pertaining to Phreesia's long-term growth outlook through expansion of its key revenue platforms and remained confident in its revenue growth projections for fiscal year 2027, while also minimizing risks from slowing growth in its Network Solutions segment, and that Phreesia's portrayal of its pharmaceutical marketing commitments as a durable growth driver of its Network Solutions segment was uncertain thereby putting the 2027 revenue target at risk.

Those who purchased shares of Phreesia, Inc. (NYSE: PHR) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.